Your browser doesn't support javascript.
loading
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial.
Antonia, Scott J; López-Martin, José A; Bendell, Johanna; Ott, Patrick A; Taylor, Matthew; Eder, Joseph Paul; Jäger, Dirk; Pietanza, M Catherine; Le, Dung T; de Braud, Filippo; Morse, Michael A; Ascierto, Paolo A; Horn, Leora; Amin, Asim; Pillai, Rathi N; Evans, Jeffry; Chau, Ian; Bono, Petri; Atmaca, Akin; Sharma, Padmanee; Harbison, Christopher T; Lin, Chen-Sheng; Christensen, Olaf; Calvo, Emiliano.
Affiliation
  • Antonia SJ; H Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
  • López-Martin JA; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Bendell J; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN, USA.
  • Ott PA; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Taylor M; Oregon Health & Science University, Portland, OR, USA.
  • Eder JP; Yale Comprehensive Cancer Center, New Haven, CT, USA.
  • Jäger D; Nationales Centrum für Tumorerkrankungen (NCT), University Medical Center, Heidelberg, Germany.
  • Pietanza MC; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Le DT; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA.
  • de Braud F; Fondazione IRCCS Istituto Nazionale dei Tumori Milano, Milan, Italy.
  • Morse MA; Duke University Medical Center, Durham, NC, USA.
  • Ascierto PA; Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy.
  • Horn L; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Amin A; Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA.
  • Pillai RN; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Evans J; University of Glasgow, Glasgow, UK.
  • Chau I; Royal Marsden Hospital, Sutton, UK.
  • Bono P; Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Atmaca A; Krankenhaus Nordwest UCT-University Cancer Center, Frankfurt, Germany.
  • Sharma P; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Harbison CT; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Lin CS; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Christensen O; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Calvo E; START Madrid, Centro Integral Oncológico Clara Campal, Madrid, Spain. Electronic address: emiliano.calvo@start.stoh.com.
Lancet Oncol ; 17(7): 883-895, 2016 Jul.
Article in En | MEDLINE | ID: mdl-27269741
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Small Cell Lung Carcinoma / Lung Neoplasms / Neoplasm Recurrence, Local Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Small Cell Lung Carcinoma / Lung Neoplasms / Neoplasm Recurrence, Local Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2016 Type: Article